These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of the Symbiosis with Margarita V; Cao LC; Bailey NP; Ngoc THT; Ngo TMC; Nu PAT; Diaz N; Dessì D; Hirt RP; Fiori PL; Rappelli P Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740218 [TBL] [Abstract][Full Text] [Related]
24. The presence of Mycoplasma hominis in isolates of Trichomonas vaginalis impacts significantly on DNA fingerprinting results. Xiao JC; Xie LF; Zhao L; Fang SL; Lun ZR Parasitol Res; 2008 Mar; 102(4):613-9. PubMed ID: 18058131 [TBL] [Abstract][Full Text] [Related]
25. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates. Goodhew EB; Secor WE Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105 [TBL] [Abstract][Full Text] [Related]
26. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203 [TBL] [Abstract][Full Text] [Related]
27. Rapid detection of coinfections by Trichomonas vaginalis, Mycoplasma hominis, and Ureaplasma urealyticum by a new multiplex polymerase chain reaction. Diaz N; Dessì D; Dessole S; Fiori PL; Rappelli P Diagn Microbiol Infect Dis; 2010 May; 67(1):30-6. PubMed ID: 20385350 [TBL] [Abstract][Full Text] [Related]
28. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis]. Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960 [TBL] [Abstract][Full Text] [Related]
30. Mycoplasma hominis and Trichomonas vaginalis symbiosis: multiplicity of infection and transmissibility of M. hominis to human cells. Rappelli P; Carta F; Delogu G; Addis MF; Dessì D; Cappuccinelli P; Fiori PL Arch Microbiol; 2001 Jan; 175(1):70-4. PubMed ID: 11271423 [TBL] [Abstract][Full Text] [Related]
32. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Narcisi EM; Secor WE Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451 [TBL] [Abstract][Full Text] [Related]
33. Genetic relatedness of Trichomonas vaginalis reference and clinical isolates. Cornelius DC; Mena L; Lushbaugh WB; Meade JC Am J Trop Med Hyg; 2010 Dec; 83(6):1283-6. PubMed ID: 21118935 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates. Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504 [TBL] [Abstract][Full Text] [Related]
35. Entry and intracellular location of Mycoplasma hominis in Trichomonas vaginalis. Vancini RG; Benchimol M Arch Microbiol; 2008 Jan; 189(1):7-18. PubMed ID: 17710384 [TBL] [Abstract][Full Text] [Related]
36. Comparison of in vitro activity of metronidazole and garlic-based product (Tomex®) on Trichomonas vaginalis. Ibrahim AN Parasitol Res; 2013 May; 112(5):2063-7. PubMed ID: 23455944 [TBL] [Abstract][Full Text] [Related]
37. [Comparison of Conventional Methods with Molecular Methods in the Diagnosis of Trichomonas vaginalis and Investigation of Metronidazole Resistance]. Özel Y; Çavuş İ; Usta A; Vardar Ünlü G; Özbilgin A; Ünlü M Mikrobiyol Bul; 2023 Oct; 57(4):625-638. PubMed ID: 37885390 [TBL] [Abstract][Full Text] [Related]
38. Association of Trichomonas vaginalis with its symbiont Mycoplasma hominis synergistically upregulates the in vitro proinflammatory response of human monocytes. Fiori PL; Diaz N; Cocco AR; Rappelli P; Dessì D Sex Transm Infect; 2013 Sep; 89(6):449-54. PubMed ID: 23633668 [TBL] [Abstract][Full Text] [Related]
39. The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions. Argáez-Correa W; Alvarez-Sánchez ME; Arana-Argáez VE; Ramírez-Camacho MA; Novelo-Castilla JS; Coral-Martínez TI; Torres-Romero JC J Eukaryot Microbiol; 2019 Mar; 66(2):309-315. PubMed ID: 30047563 [TBL] [Abstract][Full Text] [Related]
40. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Seña AC; Bachmann LH; Hobbs MM Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]